Cargando…
Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells
BACKGROUND: The polyether antibiotic Salinomycin (Sal) is regarded as an inhibitor of cancer stem cells. Its effectiveness on human colorectal cancer (CRC) cells in vitro has been demonstrated before. The aim of this study was to establish a murine model to investigate the effectiveness of Sal in vi...
Autores principales: | Klose, Johannes, Eissele, Jana, Volz, Claudia, Schmitt, Steffen, Ritter, Alina, Ying, Shen, Schmidt, Thomas, Heger, Ulrike, Schneider, Martin, Ulrich, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114842/ https://www.ncbi.nlm.nih.gov/pubmed/27855654 http://dx.doi.org/10.1186/s12885-016-2879-8 |
Ejemplares similares
-
Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model
por: Klose, Johannes, et al.
Publicado: (2019) -
Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex
por: Wang, Zhongyuan, et al.
Publicado: (2019) -
Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment
por: Mao, J, et al.
Publicado: (2014) -
Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
por: Jung, Youn-Sang, et al.
Publicado: (2015) -
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
por: Li, Rui, et al.
Publicado: (2017)